McAlpine's Multiple Sclerosis

Autorzy:

Wydawca: Churchill Livingstone

ISBN: 9780443072710

1 213,38 zł

1 092,04 zł Zniżka 121,34 zł Brutto

Najniższa cena w okresie 30 dni przed promocją: 1 092,04 zł

Ilość

Od 4 do 6 tygodni

Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

Since 1955, this landmark masterwork has been revered for its authoritative presentation of the entire state of scientific and clinical knowledge about multiple sclerosis. This new edition summarises the state of knowledge on this common neurological disease to mid-2005. No person who aspires to know about multiple sclerosis can do without this book!

The state-of-the-art 4th Edition presents the most recent information on the genetics and epidemiology, clinical neurology, pathogenesis, and management of this common neurological disease.

Amply illustrated and referenced and beautifully written, McAlpines Multiple Sclerosis has been described as A standard reference for multiple sclerosis researchers, embryonic MS-ologists and hard-pressed clinical neurologists alike (Brain, review of the last edition).

Szczegóły produktu

Wydawca Churchill Livingstone

Indeks 33770

EAN13 9780443072710

ISBN 9780443072710

Opis

Rok wydania: 2005
Numer wydania: 4
Oprawa: twarda
Liczba stron: 992
Wymiary (mm): 276 x 219
Waga (g): 3175

SECTION ONE: THE STORY OF MULTIPLE SCLEROSIS

1. The story of multiple sclerosis

The evolving concept of multiple sclerosis

Naming and classifying the disease: 1868-1983

Clinical descriptions of multiple sclerosis: 1838-1981

Personal accounts of multiple sclerosis: 1824-1991

The social history of multiple sclerosis: 1945-1998

The pathogenesis and clinical anatomy of multiple sclerosis: 1849-1977

The laboratory science of multiple sclerosis: 1912-1981

Discovery of glia and remyelination: 1858-1988

The aetiology of multiple sclerosis: 1883-1976

Attitudes to the treatment of multiple sclerosis: 1841-1983

SECTION TWO: THE CAUSE AND COURSE OF MULTIPLE SCLEROSIS

2. The distribution of multiple sclerosis

The rationale for epidemiological studies in multiple sclerosis

Definitions and statistics in epidemiology

Strategies for epidemiological studies in multiple sclerosis

The geography of multiple sclerosis

Epidemics and clusters of multiple sclerosis

The environmental factor in multiple sclerosis

3. The genetics of multiple sclerosis:

Genetic analysis of multiple sclerosis

Methods of genetic analysis

Racial susceptibility

Sex differences in susceptibility

Familial multiple sclerosis

Candidate genes in multiple sclerosis

Systematic genome screening

Lessons from genetic studies of experimental allergic encephalomyelitis

Conclusions

4. The natural history of multiple sclerosis

Introduction

Definitions

Onset

Course

Inter-individual variability

Factors affecting the prognosis

General considerations

Environmental influences

Chapter 5: The aetiology of multiple sclerosis: an epitome

SECTION THREE: THE CLINICAL FEATURES AND DIAGNOSIS OF MULTIPLE SCLEROSIS

6. The symptoms and signs of multiple sclerosis.

Multiple sclerosis as a neurological illness

Initial symptoms

Symptoms and signs in the course of the disease

Individual symptoms and sign

Associated diseases

Conclusion

7. The diagnosis of multiple sclerosis

Diagnostic criteria for multiple sclerosis

Selection of investigations

Magnetic resonance imaging

Evoked potentials

Examination of the cerebrospinal fluid

A strategy for the investigation of demyelinating disease

8. The differential diagnosis of multiple sclerosis

The spectrum of disorders mimicking multiple sclerosis

Diseases that may cause multiple lesions of the CNS and also often follow a relapsing remitting course

Systematized central nervous system diseases

Isolated or monosymptomatic CNS syndromes

Non organic symptoms

How accurate is the diagnosis of multiple sclerosis?

9. Multiple sclerosis in the individual and in groups: a conspectus

The typical case

Isolated syndromes and their outcome: judicious use of investigations and critique of the new diagnostic criteria

Co-morbidity and associated diseases

Situations in which alternative diagnoses should be considered

When to ignore inconvenient” laboratory results or clinical findings: taking the best position

Pathognomonic” and un-heard of” features of multiple sclerosis

SECTION FOUR: THE PATHOGENESIS OF MULTIPLE SCLEROSIS

10. The neurobiology of multiple sclerosis.

Organisation in the central nervous system

Development of the central nervous system

Macroglial lineages in the rodent and human nervous system

Axon-glial interactions and myelination

Demyelination

Axon degeneration and restoration of function
Remyelination

11. The immunology of inflammatory demyelinating disease

Multiple sclerosis as an autoimmune disease

Immune responses: innate and adaptive

T lymphocytes

B lymphocytes

Autoimmunity and self tolerance in the central nervous system

Regulation of central nervous system autoimmune responses

Immune reactivity in the central nervous system

Pathogenesis of demyelination and tissue damage

Peripheral blood biomarkers for multiple sclerosis and disease activity

Markers of multiple sclerosis and disease activity in cerebrospinal fluid

Conclusion

12. The pathology of multiple sclerosis

Introduction

Pathological classification of demyelinating diseases

The demyelinated plaque

Immunopathology of inflammation

Demyelination and oligodendroglial damge

Remyelination

Axonal pathology

Grey matter pathology / cortical plaques

Astroglia reaction

Abnormalities in the normal” white matter

Distribution of lesions in the nervous system

Is there evidence for an infectious agent in the lesions of multiple sclerosis?

Dynamic evolution of multiple sclerosis pathology

Differences between acute relapsing and progressive multiple sclerosis

Molecular approaches to the study of the MS lesion: Global profiling of transcriptome and proteome.

Association of multiple sclerosis with other diseases

Conclusions

13. The pathophysiology of multiple sclerosis

Introduction

Methods for exploring the pathophysiology of multiple sclerosis

Relapsing remitting multiple sclerosis: loss of function due to conduction block

Relapsing remitting multiple sclerosis: recovery of function and remission

Physiological explanations for other clinical symptoms in multiple sclerosis

Permanent loss of function in the context of disease progression

Summary

SECTION FIVE: THE TREATMENT OF MULTIPLE SCLEROSIS

15. Care of the person with multiple sclerosis

General approach to the care of people with multiple sclerosis

The early stages of disease: minimal disability

The middle stages of disease: moderate disability

The later stages of disease: severe disability

Guidelines for the management and investigation of multiple sclerosis

Conclusion

16. Treatment of the acute relapse

The features of active multiple sclerosis

The treatment of relapse in multiple sclerosis

Other approaches to the treatment of acute relapse

Treatment of acute optic neuritis

Management of other central nervous system demyelinating disorders

Adverse effects of corticosteroids

Mode of action of corticosteroids

Practice Guidelines

17. The treatment of symptoms in multiple sclerosis and the role of rehabilitation

The general principles of symptomatic treatment in multiple sclerosis

Disturbances of autonomic function

Mobility and gait disturbance

Fatigue

Disturbances of brain stem function

Perturbations of nerve conduction

Cognition

Visual symptoms

Rehabilitation in multiple sclerosis

Summary

18. Disease modifying treatments in multiple sclerosis

The aims of disease modifying treatment

The principles of evidence based prescribing in multiple sclerosis

The role of magnetic resonance imaging in clinical trials

Drugs that stimulate the immune response

Drugs that non-specifically suppress the immune response

The beta interferons

Molecules that inhibit T cell-peptide binding

Specific treatments that target T cells

Agents which inhibit macrophages and their mediators

Recent miscellaneous treatments

Postscript

19: The person with multiple sclerosis: present and future

Empirical versus hypothesis driven therapeutics

New opportunities for immunological intervention

Axon protection; acute and chronic

Treatment in special situations

Remyelination:

Index

Komentarze (0)

Często kupowane razem

Brak dostępnych produktów

McAlpine's Multiple Sclerosis

Często kupowane razem